Roche India gets CDSCO panel nod to manufacture, market anticancer drug Entrectinib capsules Dr. Divya Colin1 April 2022 6:20 PM ISTNew Delhi: Drug major, Roche Products has got approval from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
MSN Laboratories gets CDSCO panel nod for FDCs Solifenacin, Mirabegron capsules Dr. Divya Colin30 March 2022 7:21 PM ISTNew Delhi: In a significant development, MSN Laboratories has got approval from the Subject Expert Committee (SEC) of the Central Drugs Standard...
Glenmark gets CDSCO panel nod for Phase 4 study of anti-diabetic FDC drug Dr. Divya Colin21 March 2022 6:37 PM ISTNew Delhi: In line with the drug major Glenmark Pharmaceutical's revised Phase IV clinical trial protocol for anti-diabetic fixed dose combination...
Natco Pharma gets CDSCO nod to manufacture, market anti neoplastic drug Idelalisib Dr. Divya Colin16 March 2022 6:52 PM ISTNew Delhi: In a significant development, Natco Pharma has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control...
Bristol Myers Squibb Nivolumab marketing approval to be revoked for hepatocellular carcinoma: CDSCO panel Dr. Divya Colin14 March 2022 6:30 PM ISTNew Delhi: In a major setback for Bristol Myers Squibb, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Dr. Roddy's gets CDSCO panel nod to manufacture & market Treprostinil solution for Infusion Dr. Divya Colin12 March 2022 1:51 PM ISTNew Delhi: Granting a local clinical trial waiver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
Roche India Atezolizumab marketing approval to be revoked for two indications: CDSCO panel Susmita Roy10 March 2022 6:50 PM ISTNew Delhi: In a major setback to Roche Products (India), the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Sanofi gets CDCSO panel okay to study Antiasthmatic drug Dupilumab Dr. Divya Colin9 March 2022 6:58 PM ISTNew Delhi: Pharmaceutical major, Sanofi has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization...
Lupin gets CDSCO panel okay to manufacture, market tuberculosis drug Rifapentine Dr. Divya Colin5 March 2022 5:35 PM ISTNew Delhi: Drug major, Lupin has got a go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization to (CDSCO)...
Serdia Pharma gets CDSCO nod for anti-diabetic FDC of extended-release Gliclazide 60mg plus Metformin 1000mg tablet Susmita Roy18 Feb 2022 1:34 PM ISTNew Delhi: In a significant development, Serdia® Pharmaceuticals (India) Pvt. Ltd. has got approval from the Central Drugs Standard Control...
Sun Pharma gets CDSCO panel okay for phase 3 trial of Pimavanserin Dr. Divya Colin29 Jan 2022 12:51 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Hetero Labs, Optimus proposal to launch generic Paxlovid rejected by CDSCO panel: Report Dr. Divya Colin27 Jan 2022 6:10 PM ISTNew Delhi: In a major setback to Hetero Labs and Optimus Pharma, Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
